Vaxxinity
Presence
Vaxxinity is a company listed under the stock ticker VAXX (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Vaxxinity
- Mei Mei Hu, President, Chief Executive Officer and Director
- Lou Reese, Executive Chairman of the Board
- Landon Ogilvie, Director
Popular executive movements at Vaxxinity
- Katherine Eade, Director, has left the company (posted on December 3 2023).
- Paula Molina, General Counsel and Secretary, will leave the company on Nov. 3, 2023 (posted on September 29 2023).
- Sumita Ray will join the company as Chief Legal & Administrative Officer on Oct. 1, 2023 (posted on September 29 2023).
Create your alert
to follow the executive moves at Vaxxinity.
Biotechnology
Vaxxinity has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Vaxxinity
- Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Vaxxinity
- Vaxxinity to Present at Upcoming November Medical and Investor Conferences | Vaxxinity
- Vaxxinity to Present at Upcoming Investor Conferences in September | Vaxxinity
- Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update | Vaxxinity
- Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease | Vaxxinity
Social media about Vaxxinity
- Vaxxinity on Wikipedia, Google News & Yahoo Finance
- Vaxxinity on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mei Mei Hu 
